Intervention

Levothyroxine

ClinicalTrials.gov intervention label

Clinical trials7

Recruiting2

Common conditions10

Lead sponsors shown6

Clinical trials

7 shown

Levothyroxine as Adjuvant to a Hypocaloric Diet for the Treatment of Obesity.NCT07332273 · 2025-11-05

Levothyroxine Supplementation for Heart Transplant RecipientsNCT06428097 · 2024-03-29

Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF)NCT03096613 · 2017-04-18

A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokinetics of Semaglutide Administered Orally in Healthy Subjects.NCT02920385 · 2016-10-10

The TRUST Study - CardioVascular Imaging IMTNCT02832934 · 2016-06-01

The TRUST Trial - CardioVascular Imaging ECHONCT02832960 · 2016-06-01

Levothyroxine (L-T4) Absorption After Bariatric SurgeryNCT01189344 · 2007-09-01

Common conditions

Heart Failure3 Atherosclerosis2 Thyroid Dysfunction2 Diabetes1 Healthy1 Heart Transplant Failure1 Heart Transplant Infection1 Morbid Obesity1 Obesity1 Subclinical Hypothyroidism1

Leading sponsors

Insel Gruppe AG, University Hospital Bern2 Chinese Academy of Medical Sciences, Fuwai Hospital1 Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud1 Novo Nordisk A/S1 University of California, San Francisco1 University of Sao Paulo1

Trial status mix

COMPLETED4

RECRUITING2

UNKNOWN1

Phase mix

PHASE43

PHASE12

NA1

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.